These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4442544)

  • 21. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.
    Schechter MD; Rosecrans JA
    Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts.
    Kleinman JE; Gillin JC; Wyatt RJ
    Schizophr Bull; 1977; 3(4):560-86. PubMed ID: 271353
    [No Abstract]   [Full Text] [Related]  

  • 23. Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine).
    Lin RC; Ngai SH; Costa E
    Science; 1969 Oct; 166(3902):237-9. PubMed ID: 5809595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative activity of psychotoxic drugs on the avian optic lobe.
    Scholes NW; Gutnick MJ
    Eur J Pharmacol; 1970; 12(3):289-96. PubMed ID: 5531373
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of lysergic acid diethylamide on the permeability of the blood-brain barrier in rats].
    Maĭzelis MIa
    Biull Eksp Biol Med; 1967 Jun; 63(6):51-3. PubMed ID: 5622612
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms of action of LSD.
    Jacobs BL; Trulson ME
    Am Sci; 1979; 67(4):396-404. PubMed ID: 533027
    [No Abstract]   [Full Text] [Related]  

  • 27. Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
    Whelan A; Johnson MI
    Pain Manag; 2018 May; 8(3):217-229. PubMed ID: 29722608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits.
    Ladefoged O
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):251-4. PubMed ID: 4277695
    [No Abstract]   [Full Text] [Related]  

  • 29. Possible role of biochemiluminescent photons for lysergic acid diethylamide (LSD)-induced phosphenes and visual hallucinations.
    Kapócs G; Scholkmann F; Salari V; Császár N; Szőke H; Bókkon I
    Rev Neurosci; 2017 Jan; 28(1):77-86. PubMed ID: 27732562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats.
    Ladefoged O
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):326-32. PubMed ID: 4270656
    [No Abstract]   [Full Text] [Related]  

  • 31. Relief of obsessive-compulsive symptoms by LSD and psilocin.
    Leonard HL; Rapoport JL
    Am J Psychiatry; 1987 Sep; 144(9):1239-40. PubMed ID: 3631327
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Auto-experimentation with LSD-25 and psilocybin].
    CALANCA A
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 92():236-8. PubMed ID: 14017795
    [No Abstract]   [Full Text] [Related]  

  • 34. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
    Holze F; Ley L; Müller F; Becker AM; Straumann I; Vizeli P; Kuehne SS; Roder MA; Duthaler U; Kolaczynska KE; Varghese N; Eckert A; Liechti ME
    Neuropsychopharmacology; 2022 May; 47(6):1180-1187. PubMed ID: 35217796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of LSD-25 and 1-methyl-d-lysergic acid butanolamide on rat brain and platelet serotonin levels.
    Torre M; Bogetto F; Torre E
    Psychopharmacologia; 1974 Apr; 36(2):117-22. PubMed ID: 4407808
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
    Pieri L; Keller HH; Burkard W; Da Prada M
    Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mood, behavior and drugs].
    Monti A
    Minerva Med; 1971 May; 62(40 Suppl):33-4. PubMed ID: 5555948
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of the reactions induced by psilocybin and LSD-25 in man.
    ISBELL H
    Psychopharmacologia; 1959; 1():29-38. PubMed ID: 14405870
    [No Abstract]   [Full Text] [Related]  

  • 39. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
    Snyder SH; Faillace L; Hollister L
    Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
    Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
    Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.